Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 425-431

  Arnaud, Claire ^a,b   Poulain, Laureline ^a,b   Lévy, Patrick ^a,b,c   Dematteis, Maurice ^a,b,c  

^a University Grenoble Alpes   (France)

^b UNIV GRENOBLE ALPES   (France)

^c HÔPITAL MICHALLON   (France)

Author keywords

Atherosclerosis; Dyslipidemia; Inflammation; Intermittent hypoxia; Mice; Sleep apnea

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 4; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; CYTOKINE RELEASE; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; DISEASE SEVERITY; HEMATOCRIT; HYPERTENSION; HYPOXIA; INTERMITTENT HYPOXIA; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULITIS;

ANIMALS; ANOXIA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PRESSURE; CELLS, CULTURED; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; TIME FACTORS;

EID: 82955246272     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.122     Document Type: Article

References (34)

1. Young T., Finn L., Peppard P.E., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31:1071-1078.
2. Somers V.K., White D.P., Amin R., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008, 52:686-717.
3. Punjabi N.M., Caffo B.S., Goodwin J.L., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.
4. Baguet J.P., Hammer L., Lévy P., et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005, 128:3407-3412.
5. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:613-618.
6. Drager L.F., Bortolotto L.A., Figueiredo A.C., Krieger E.M., Lorenzi G.F. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712.
7. Jun J., Polotsky V.Y. Metabolic consequences of sleep-disordered breathing. ILAR J 2009, 50:289-306.
8. McNicholas W.T., Bonsignore M.R. Management committee of EU COST ACTION B26 sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007, 29:156-178.
9. Arnaud C., Dematteis M., Pépin J.L., Baguet J.P., Lévy P. Obstructive sleep apnea syndrome, immuno-inflammation and atherosclerosis. Semin Immunopathol 2009, 31:113-125.
10. Savransky V., Nanayakkara A., Li J., et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 2007, 175:1290-1297.
11. Jun J., Reinke C., Bedja D., et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2010, 209:381-386.
12. Li J., Savransky V., Nanayakkara A., Smith P.L., O'Donnell C.P., Polotsky V.Y. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 2007, 102:557-563.
13. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
14. Dematteis M., Julien C., Guillermet C., et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 2008, 177:227-235.
15. Dematteis M., Godin-Ribuot D., Arnaud C., et al. Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding of the human disease. ILAR J 2009, 50:262-281.
16. Arnaud C., Beguin P.C., Lantuejoul S., et al. The Inflammatory pre-atherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. Am J Respir Crit Care Med 2011, (June). PMID: 21680945.
17. Meir K.S., Leitersdorf E. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004, 24:1006-1014.
18. Kwak B.R., Veillard N., Pelli G., et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003, 107:1033-1039.
19. Lévy P., Pépin J.L., Arnaud C., Baguet J.P., Dematteis M., Mach F. Obstructive sleep apnea and atherosclerosis. Prog Cardiovasc Dis 2009, 51:400-410.
20. Kanagy N.L. Vascular effects of intermittent hypoxia. ILAR J 2009, 53:282-288.
21. Lee E.J., Woodske M.E., Zou B., O'Donnell C.P. Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J Appl Physiol 2009, 107:290-294.
22. Snow J.B., Kitzis V., Norton C.E., et al. Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity. J Appl Physiol 2008, 104:110-118.
23. Hansson G.K. Inflammation atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
24. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
25. Baguet J.P., Lévy P., Barone-Rochette G., et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008, 26:885-892.
26. Tamisier R., Pépin J.L., Rémy J., et al. 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J 2011, 37:119-128.
27. Chatzizisis Y.S., Coskun A.U., Jonas M., Edelman E.R., Feldman C.L., Stone P.H. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007, 49:2379-2393.
28. Ryan S., Taylor C.T., McNicholas W.T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Thorax 2009, 64:631-636.
29. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998, 392:565-568.
30. Dyugovskaya L., Lavie P., Hirsh M., Lavie L. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 2005, 25:820-828.
31. Dyugovskaya L., Lavie P., Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 2005, 1051:340-350.
32. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
33. Robertson A.K., Hansson G.K. T cells in atherogenesis: for better or for worse?. Arterioscler Thromb Vasc Biol 2006, 26:2421-2432.
34. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8:802-815.